Clinical Trials

Can AI Predict Autoimmune Disease Progression with Greater Accuracy?
Tech & Innovation Can AI Predict Autoimmune Disease Progression with Greater Accuracy?

Autoimmune diseases occur when the immune system erroneously targets the body's own cells and tissues. These diseases usually present a preclinical stage with mild symptoms or specific antibodies detectable in blood tests before the disease fully manifests. However, in some cases, these

Insilico Medicine's AI-Driven Drug ISM5411 Shows Promise for Treating IBD
Tech & Innovation Insilico Medicine's AI-Driven Drug ISM5411 Shows Promise for Treating IBD

Insilico Medicine, a clinical-stage company leveraging generative artificial intelligence (AI) for drug discovery and development, has announced promising results for its novel drug, ISM5411, aimed at treating Inflammatory Bowel Disease (IBD). This gut-restricted and PHD-specific inhibitor was

Targeting Endocan: A New Hope for Treating Aggressive Brain Cancer
Research & Development Targeting Endocan: A New Hope for Treating Aggressive Brain Cancer

Glioblastoma, an aggressive and often fatal form of brain cancer, has long posed a formidable challenge to medical professionals. With an average lifespan of 12 to 15 months post-diagnosis and a mere 5% survival rate five years after diagnosis, the need for innovative treatments has never been more

How Does Penn Medicine Transform Cancer Treatment with CAR T Therapy?
Research & Development How Does Penn Medicine Transform Cancer Treatment with CAR T Therapy?

Penn Medicine’s Center for Cellular Immunotherapies (CCI) is at the forefront of revolutionizing cancer treatment through CAR (chimeric antigen receptor) T cell therapy. This innovative approach harnesses the power of the patient’s own immune system to target and destroy cancer cells, offering new h

Statistical Methods in Multicenter HIV RCTs in Africa: A Scoping Review
Research & Development Statistical Methods in Multicenter HIV RCTs in Africa: A Scoping Review

Randomized controlled trials (RCTs) are widely recognized as the gold standard for evaluating the efficacy of interventions. In the context of HIV research in Africa, multicenter RCTs are particularly valuable due to the diverse socio-cultural and geographical settings. This scoping review aims to

How Will Clinical Trials Transform with Real World Data by 2025?
Research & Development How Will Clinical Trials Transform with Real World Data by 2025?

The landscape of clinical trials is on the brink of a significant transformation, driven by the integration of Real World Data (RWD). By 2025, the use of RWD is expected to revolutionize the way clinical trials are conducted, offering new opportunities for efficiency, accuracy, and patient-centric

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later